urinary%20tract%20infection%20-%20uncomplicated
URINARY TRACT INFECTION - UNCOMPLICATED
Acute uncomplicated urinary tract infection (UTI) is one of the most common bacterial infections in adults that may involve the lower or upper urinary tract or both.
Acute uncomplicated cystitis is an infection limited to the lower urinary tract while acute uncomplicated pyelonephritis is an infection that involves the upper urinary tract (renal parenchyma and pelvicaliceal system) that usually has significant bacteriuria.
Recurrent UTI is characterized by 2 culture-proven episodes of uncomplicated and/or complicated UTI in the last 6 months or ≥3 episodes with positive cultures in the last 12 months in patients with no urinary tract structural or functional abnormalities.

Urinary%20tract%20infection%20-%20uncomplicated Management

Indications For Hospital Admission

  • Severely ill or evidence of sepsis
  • Presence of complications
  • Concern about compliance
  • Failure to respond to outpatient treatment
  • Inability to maintain oral hydration or take medications, vomiting, dehydration
  • Uncertainty about the diagnosis

Follow Up

Acute Uncomplicated Cystitis 

  • Routine post-treatment urinalysis or culture is not indicated in asymptomatic patients
  • Urine culture and antimicrobial susceptibility testing are indicated in patients who remain symptomatic after completion of treatment or if patient has recurrence of symptoms within 2 weeks
    • Retreatment with another agent for 7 days should be considered
  • Antimicrobial agent must be changed empirically pending the result of post-treatment urine culture and sensitivity testing in patients showing poor response to therapy

Acute Uncomplicated Pyelonephritis 

  • After improvement, which is usually apparent within 48-72 hours, switch parenteral antibiotic to oral regimen to complete 1- to 2-week course of therapy
  • Post-treatment urinalysis and urine culture are not needed in patients who respond and remain asymptomatic
  • Radiologic (eg renal ultrasound, CT or renal scintigraphy) and urologic evaluation, and repeat urine culture/susceptibility testing are indicated in patients who remain febrile within ≥72 hours of treatment or if patient has recurrence of symptoms within 2 weeks
    • Alternative tailored treatment should be considered in the absence of urological abnormality
    • Rule out possible complications (eg nephrolithiasis, renal or perirenal abscess) in patients who relapse with the same pathogen
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 6 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
2 days ago
Nocturia is a risk factor for mortality, according to the results of the Nagahama Study, which boasts of a low incidence of missing data and high representation of the general population.
Audrey Abella, 14 Oct 2020
Despite a 90-percent cure rate after first treatment for children with acute lymphoblastic leukaemia (ALL), approximately 10–15 percent of patients with paediatric ALL will experience relapse. [Expert Rev Anticancer Ther 2017;17:725-736] A recent webinar on the current landscape of ALL highlighted the potential of immunotherapy for paediatric patients with relapsed or refractory ALL, thus providing hope for this high-risk patient group.